Casper Pharmaceuticals
Private Company
Funding information not available
Overview
Casper Pharma is a privately held, commercial-stage specialty pharmaceutical company headquartered in Princeton, New Jersey, USA. Founded in 2018, it operates a business model centered on acquiring, developing, and commercializing established and niche pharmaceutical products across several chronic disease areas. The company appears to be revenue-generating with a marketed product, Triglide, and is led by a team of experienced pharmaceutical executives. Its strategy focuses on leveraging a global network to identify and fulfill unmet medical needs with cost-effective therapies.
Technology Platform
Leverages a global pharmaceutical network for identifying, acquiring, developing, and commercializing pharmaceutical products, with a focus on improved formulations and delivery of existing therapies.
Opportunities
Risk Factors
Competitive Landscape
Casper competes in crowded specialty therapeutic areas against large, integrated pharmaceutical companies with vast resources, as well as numerous generic and other specialty pharma companies. Its differentiation is based on strategic product selection, cost-effective commercialization, and a focus on patient access rather than novel science.